Impact of misunderstanding genetic tests for heart conditions

February 23, 2018

University of Sydney researchers are raising concerns over the need for informed decision making for genetic testing after a study published today finds patients at risk of inherited heart disease do not always understand test results or the impact results will have on their life.

Genetic testing has become increasingly accessible for many diseases including heart conditions such as hypertrophic cardiomyopathy (HCM). HCM is an inherited heart disease that increases the thickness of the heart wall which can lead to serious consequences including sudden cardiac death in young people. First degree relatives (parents, children, siblings) of an affected person have a 50 per cent chance inheriting the same gene mutation.

"With more and more people getting genetic testing for this condition, there is now a growing population of "silent gene carriers" being identified - these are people whose carry the gene but have no physical signs of disease," said researcher Dr Carissa Bonner from the School of Public Health.

"Little is known about how a positive genetic test result for HCM affects newly diagnosed patients who are at risk but may never develop symptoms.

"The issue facing patients is that genetic test results only indicate that they may be at risk of developing hypertrophic cardiomyopathy, not that they already had the disease.

"The question we're asking is: Would they be better off not knowing?"

Dr Bonner said the interpretation of the HCM genetic test results was variable for silent gene carriers and can lead to psychological and behavioural changes.

"There were a number of psychological and behavioural changes made by patients who received a positive result on their genetic test that they didn't necessarily consider when making the decision about whether or not to be tested.

"This included shock and anxiety about the test result, worry about developing symptoms, worry about children, family planning decisions, and restrictions on physical activity, career options and access to travel insurance.

"We found that when considering genetic testing, most people were motivated by helping their children or grandchildren. They wanted to rule out the possibility for the next generation, which meant they weren't really thinking about the impact on their own lives."

She said negative impacts tended to be more common in patients who misinterpreted the genetic testing results and these impacts could be reduced through clearer communication prior to testing.

"Those who believed they were at very high risk of heart problems described depression and anxiety, reducing the intensity of exercise, changing career, seeking medical advice for fertility and heart palpitations, and difficulty getting insurance because they voluntarily disclosed the test result.

"Those impacts appeared to be more likely when the patient misunderstood the positive genetic test to mean they had a current heart condition, which is not actually the case.

"The findings illustrate the importance of cardiac genetic counselling prior to the test, and the need for more comprehensive communication around the meaning and implications of the test result so patients can be better informed to make life decisions," Dr Bonner said.

The study was published in the Journal of Genetic Counseling.
-end-


University of Sydney

Related Genetic Testing Articles from Brightsurf:

Genetic testing cost effective for newly diagnosed GIST
UC San Diego School of Medicine researchers reported that genetic testing is cost-effective and beneficial for newly diagnosed patients with metastatic gastrointestinal stromal tumors (GIST), a rare type of cancer.

Genetic testing could improve screening for osteoporosis
An international team of scientists has developed a novel genetic measure that could dramatically improve how doctors assess the risk of sustaining a fracture due to osteoporosis or fragility

New recommendations on genetic testing for prostate cancer
Genetic testing for prostate cancer is still not common. New guidelines show why it's important, and which genes to test for.

For acute myeloid leukemia, genetic testing is often worth the wait
New tailored therapies offer exciting prospects for treating acute myeloid leukemia (AML), but taking advantage of them may require waiting a week or more for genetic testing before starting treatment, posing a dilemma for doctors and patients facing this deadly and often fast-moving disease.

Genetic testing among individuals with ASD
Professional medical societies recommend certain genetic tests for individuals with autism spectrum disorder (ASD).

Breast cancer patients to be evaluated for genetic testing
The guidance from the ACMG differs from a consensus guideline issued in February by the American Society of Breast Surgeons, which recommended genetic testing for all newly diagnosed patients with breast cancer.

New technique isolates placental cells for non-invasive genetic testing
A new technique for isolating cells carrying the full fetal genome from cervical swabs could enable doctors to diagnose genetic disorders without using needles to harvest cells from the placenta.

BRCA1/2 genetic testing recommendations still leave issues unresolved
The U.S. Preventive Services Task Force offers new guidelines on BRCA1/2 genetic testing.

Does genetic testing pose psychosocial risks?
For the last quarter century, researchers have been asking whether genetic information might have negative psychosocial effects.

Genetic testing has a data problem; New software can help
As at-home genetic testing becomes more popular, companies are grappling with how to store all the accumulating data and how to process results quickly.

Read More: Genetic Testing News and Genetic Testing Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.